Koyfin Home > Directory > Health Care > Alexion Pharm Inc > EBITDA Margin

Alexion Pharm Inc EBITDA Margin Chart (ALXN)

Alexion Pharm Inc annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Alexion Pharm Inc EBITDA Margin for the quarter ending September 09, 2020 was $53m a 16.46% increase of 9m year over year
  • Alexion Pharm Inc EBITDA Margin for the last 12 months ending September 09, 2020 was $53m a 5.55% increase of 3m year over year
  • Alexion Pharm Inc Annual EBITDA Margin for 2019 was $50m a 3.22% increase of 2m from 2018
  • Alexion Pharm Inc Annual EBITDA Margin for 2018 was $48m a 15.37% increase of 7m from 2017
  • Alexion Pharm Inc Annual EBITDA Margin for 2017 was $41m a 7.63% increase of 3m from 2016
Other Margins & Efficiency Metrics:
  • Alexion Pharm Inc Return on Capital % for the quarter ending December 12, 2018 was 8.64 a 20.76% increase of 1.79 year over year
  • Alexion Pharm Inc Return on Equity % for the quarter ending December 12, 2018 was -1.96 a 663.73% decrease of -13.03 year over year
View Chart On Koyfin

Quarterly ALXN EBITDA Margin Data

09/2020$53m
06/2020$55m
03/2020$57m
12/2019$44m
09/2019$52m
06/2019$53m
03/2019$52m
12/2018$44m
09/2018$52m
06/2018$50m

Annual ALXN EBITDA Margin Data

2019$50m
2018$48m
2017$41m
2016$38m
2015$32m
2014$43m
2013$39m
2012$37m
2011$33m
2010$30m